Hematology/Oncology News

In our prior blog post, we discussed the frequent need to separate, from a legal and financial perspective, the real property from the practice in order to consummate a practice transaction with a private equity buyer.

Using a levonorgestrel-releasing intrauterine system device to prevent pregnancy increased risk for breast cancer among women living in Denmark aged 15 to 49 years, according to a research letter published in JAMA.

The FDA approved tumor treating fields for use as part of combination treatment for certain patients with metastatic non-small cell lung cancer.

Clinicians in acute or post-acute care settings may delay or avoid serious illness conversations with patients whose cancer prognoses are worsening out of deference to the patient’s oncologist, according to study findings.

Disease-free survival at 3 years was significantly higher among patients with screen-detected colorectal cancer vs. those with clinically detected CRC, according to a study conducted in the Netherlands.

The addition of lurbinectedin to atezolizumab improved survival for certain adults with lung cancer, according to the agent’s manufacturer.

National Hispanic Heritage Month is observed every Sept. 15 to Oct. 15.

Billing for electronic messages through the patient portal can cause confusion and create communication barriers between clinicians and patients, according to study results.

For pregnant women on bed rest, a foam roller intervention improved lower limb venous blood flow compared with controls, mitigating deep vein thrombosis risk and muscle atrophy, researchers reported.

The rates of melanoma incidence have significantly declined since approximately 2015 in patients aged younger than 50 years while mortality also dropped in those aged younger than 60, according to a Swedish study.